Royalty pharma plc RPRX 深 沪
已收盘 07-02 16:00:00 美东时间
57.77
+1.990
+3.57%
华盛通- 最 高57.80
- 今 开56.11
- 成交量 324.53万股
- 最 低 55.62
- 昨 收 55.78
- 总市值 332.66亿
- 52周最高 57.80
- 市盈率 静 32.43
- 换手率 0.56%
- 52周最低 33.3905
- 委 比 -51.22%
- 总股本 5.76亿
- 历史最高 57.80
- 量 比 0.95
- 振 幅 3.91%
- 历史最低 22.70
- 每 手 1
- 风险率 6.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition
Zymeworks Inc. (NASDAQ:ZYME) said Monday it has agreed to acquire Theravance Biopharma Inc. (NASDAQ:TBPH) in an all-cash transaction valued at about $929 million. The deal, which aims to bolster Zymeworks’ commercial portfolio, will pay $17 per share for Theravance Biopharma shares. The companies ex...
06-29 21:20
Zymeworks to Acquire Theravance Biopharma, Inc.
Zymeworks Inc. announced its definitive agreement to acquire Theravance Biopharma, Inc. for $17 per share, totaling approximately $929 million. The acquisition adds YUPELRI® (revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for COPD, to Zymeworks' portfolio. YUPELRI® generated $266.6 million in U.S. net sales in 2025, with 12% growth over 2024, and $62.4 million in Q1 2026, a 7% increase. The transactio...
06-29 10:00
GSK to buy Nuvalent for $10.6B
GSK (GSK) has agreed to acquire U.S. biopharmaceutical company Nuvalent (NUVL) in a deal valued at approximately $10.6B. Under the agreement, GSK will launch a tender offer within ten business days to...
06-09 15:02
Royalty Pharma EVP Marshall Urist sells 13,684 shares for $721,846.84
Royalty Pharma EVP Marshall Urist sells 13,684 shares for $721,846.84 Royalty Pharma EVP, Research & Investments Marshall Urist sold 13,684 Class A ordinary shares on May 20 at a weighted average price of $52.75. Direct holdings fell to 18,197 Class A ordinary shares following the sale. An additiona
05-22 09:20
美股盘后 | GLOBE LIFE涨3.24%，Fervo Energy Company Class A涨2.96%
GLOBE LIFE涨3.24%；Fervo Energy Company Class A涨2.96%；亚玛芬体育涨2.17%
05-19 06:10
美股盘后 | Nextpower涨9.97%，Insmed Incorporated涨4.31%
Nextpower涨9.97%；Insmed Incorporated涨4.31%；荷兰国际涨3.19%
05-13 06:10
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
JP Morgan Maintains Overweight on Royalty Pharma, Raises Price Target to $58
JP Morgan analyst Chris Schott maintains Royalty Pharma (NASDAQ:RPRX) with a Overweight and raises the price target from $50 to $58.
05-08 03:44
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript
Royalty Pharma (NASDAQ:RPRX) held its first-quarter earnings conference call on...
05-06 21:56
